PDprotec® is a novel dialysis fluid developed to overcome the limitations of current PD fluids and to help patients, clinicians and health care providers to fully realize the potential offered by peritoneal dialysis.
In a randomized, placebo-controlled, multi-center Phase II study, PDprotec® demonstrated its ability to
- Reduce the risk of peritoneal membrane failure and to
- Lower the risk of peritonitis.
The study corroborated the excellent safety profile already shown in previous studies.
PDprotec® uses the anti-inflammatory, anti-infectious and other cytoprotective properties of a compound identified in research by Zytoprotec’s founders.
ICOprotec® is Zytoprotec’s next-generation cytoprotective PD solution. The product is based on a non-glucose-based (icodextrin-based) PD solution. The product is ready for clinical development.